Spinal Muscular Atrophy

• FDA label_change · 2024-09-17
  FDA Approved: EVRYSDI — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Evrysdi (risdiplam) by Genentech, updating the product label.

• FDA label_change · 2022-09-21
  FDA Approved: EVRYSDI — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Evrysdi (risdiplam) from Genentech, leading to changes to the product label.